Реблозил
(Луспатерсепт)
(25 mg)
(1 фл)
(Концентрат)
Reblozyl (luspatercept) 25 mg, original
In Stock
Summary
Luspatercept is an erythroid maturation agent used to treat anemia secondary to beta thalassemia, myelodysplastic syndromes, and neoplasms.
-
Commercial name:Реблозил
-
Сhemical name:Луспатерсепт
-
Dosage:25 mg
-
Quantity:1 фл
-
Release form:Концентрат
-
Производитель:BRISTOL MYERS
No reviews yet